Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: A prospective multicentre study (SENTI-ENDO)

The Lancet Oncology

Volumn 12, Issue 5, 2011, Pages 469-476

  Ballester, Marcos ^a   Dubernard, Gil ^b   Lécuru, Fabrice ^c   Heitz, Denis ^d   Mathevet, Patrice ^e   Marret, Henri ^f   Querleu, Denis ^g   Golfier, François ^h   Leblanc, Eric ⁱ   Rouzier, Roman ^a   Daraï, Emile ^a  

^a HÔPITAL TENON   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Poissy Saint Germain en Laye University Hospital   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f CHU BRETONNEAU   (France)

^g Claudius Regaud Comprehensive Cancer Center   (France)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEU PATENTE; DYE; NANOCIS; PATENT BLUE; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; EARLY CANCER; ENDOMETRIUM CANCER; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK FACTORS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 79955483215     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70070-5     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ Cancer statistics, 2007. CA Cancer J Clin United States 2007, 57:43-66.
2. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009, 373:125-136.
3. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008, 100:1707-1716.
4. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010, 1. CD007585.
5. Selman TJ, Mann CH, Zamora J, Khan KS A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health 2008, 8:8.
6. Altgassen C, Pagenstecher J, Hornung D, Diedrich K, Hornemann A A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 2007, 105:457-461.
7. Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 2008, 15:1523-1529.
8. Ballester M, Koskas M, Coutant C, et al. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?. BMC Cancer 2010, 10:465.
9. Bats AS, Clement D, Larousserie F, et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol 2008, 97:141-145.
10. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996, 62:169-173.
11. Delaloye JF, Pampallona S, Chardonnens E, et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol 2007, 106:89-93.
12. Delpech Y, Cortez A, Coutant C, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol 2007, 18:1799-1803.
13. Fersis N, Gruber I, Relakis K, et al. Sentinel node identification and intraoperative lymphatic mapping: first results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol 2004, 25:339-342.
14. Frumovitz M, Bodurka DC, Broaddus RR, et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 2007, 104:100-103.
15. Holub Z, Jabor A, Lukac J, Kliment L Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med Sci Monit 2004, 10:587-591.
16. Li B, Li XG, Wu LY, et al. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bull Cancer 2007, 94:1-4.
17. Lopes LA, Nicolau SM, Baracat FF, et al. Sentinel lymph node in endometrial cancer. Int J Gynecol Cancer 2007, 17:1113-1117.
18. Maccauro M, Lucignani G, Aliberti G, et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 2005, 32:569-574.
19. Niikura H, Okamura C, Utsunomiya H, et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2004, 92:669-674.
20. Pelosi E, Arena V, Baudino B, et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 2003, 24:971-975.
21. Raspagliesi F, Ditto A, Kusamura S, et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am J Obstet Gynecol 2004, 19:435-439.
22. Mikuta JJ International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 1993, 71(suppl 4):1460-1463.
23. Brémond A, Bataillard A, Thomas L, et al. Standards, options and recommendations 2000 for the management of patients with endometrial cancer (non-metastatic); abridged report. Gynecol Obstet Fertil 2002, 30:902-916.
24. Lécuru, FMP, Querleu D, Leblanc E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol (in press).
25. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002, 20:3628-3636.
26. Petru E, Luck HJ, Stuart G, Gaffney D, Millan D, Vergote I Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 2009, 143:69-74.
27. Delpech Y, Coutant C, Darai E, Barranger E Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases. Surg Oncol 2008, 17:237-245.
28. Altgassen C, Hertel H, Brandstadt A, Kohler C, Durst M, Schneider A Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008, 26:2943-2951.
29. Yokoyama Y, Maruyama H, Sato S, Saito Y Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997, 64:411-417.
30. Abu-Rustum NR, Gomez JD, Alektiar KM, et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 2009, 115:236-238.
31. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010, 375:1165-1172.
32. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987, 60(suppl 8):2035-2041.
33. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol 2000, 182:1506-1519.
34. Creasman WT, Mutch DE, Herzog TJ ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?. Gynecol Oncol 2010, 116:293-294.
35. Uccella S, Podratz KC, Aletti GD, Mariani A Lymphadenectomy in endometrial cancer. Lancet 2009, 373:1170.
36. Creutzberg CL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000, 355:1404-1411. van Putten WL.
37. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004, 92:744-751.
38. Frumovitz M, Singh DK, Meyer L, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 2004, 95:463-468.
39. Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006, 103:714-718.
40. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999, 354:896-900.
41. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010, 11:646-652.
42. Bezu C, Coutant C, Ballester M, et al. Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res 2010, 29:5.
43. International (Ludwig) Breast Cancer Study Group. Lancet 1990, 335:1565-1568. Prognostic importance of occult axillary lymph node micrometastases from breast cancers.
44. Mcguckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996, 73:88-95.
45. Weaver DL, Ashikaga T, Krag DN, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 2011, 364:412-421.
46. Hakim AA, Terada KY Sentinel node dissection in vulvar cancer. Curr Treat Options Oncol 2006, 7:85-91.
47. Knopp S, Holm R, Trope C, Nesland JM Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol Oncol 2005, 99:383-387.
48. Marchiole P, Buenerd A, Benchaib M, Nezhat K, Dargent D, Mathevet P Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 2005, 97:727-732.
49. Yabushita H, Shimazu M, Yamada H, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001, 80:139-144.